The Food and Drug Administration (FDA) performed a bioresearch monitoring inspection at Nicholas McAndrew, M.D. in Santa Monica on Feb. 6, based on information from the FDA’s website.
The most recent report concluded that Nicholas McAndrew, M.D. was not required to make changes to any of its management procedures.
The FDA carries out regular inspections at facilities nationwide to verify compliance with agency laws and regulations designed to strengthen public health. The results of these inspections are made publicly available.
The agency’s website states that the FDA is responsible for overseeing the safety and quality of human and animal drugs, biological products, medical equipment and tobacco goods.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
